A Warsaw-based startup pioneering AI-driven analysis of rare diseases has secured €1.9 million in bridging funding from international investors.
The funding was led by 4growth VC in a joint investment effort with Poland’s NCBR Funding Fund, alongside the U.S.-based TNI Fund. Funds secured will enable the corporation’s strategic expansion into new markets, specifically in Europe, South America, and Canada, laying the groundwork for a larger Series A funding round in the near term.
Meet Rohan Mehta, co-founder and Chief Executive Officer of Saventic Health. ”
Founded in 2019 by Szymon Piątkowski and Professor Grzegorz Basak, Saventic Wellbeing utilises AI-powered algorithms to enhance the diagnosis of rare diseases, outperforming traditional methods with increased accuracy and efficiency. With approximately 50 algorithms currently in operation, the corporation has already detected more than 200 individuals exhibiting unusual characteristics prior to this year.
Our global presence is marked by deployments spanning multiple regions, with collaborations in place across 11 top-tier pharmaceutical companies and a network of over 30 medical facilities spread across Poland, Germany, France, Brazil, and Canada.
The 40-strong team at Savantic Health comprises a diverse range of experts, including medical professionals, data scientists, and knowledge engineers, all focused on harnessing the power of AI to drive innovative solutions in the healthcare sector.
The corporation’s AI-powered expertise analyzes vast amounts of medical data to identify potential rare disease diagnoses affecting 450 million people globally, providing actionable insights for healthcare professionals. In response to Savantic Wellbeing, this approach yields a significantly higher success rate compared to traditional diagnostic methods, which typically necessitate 7-12 years to produce accurate results and succeed only 2-4% of the time.
“” added.
The corporation’s development strategy entails a focus on expanding into new markets and enhancing geographic diversification, with plans to ramp up operations in international locations such as Colombia and Peru. Saventic Wellness intends to expand its reach into the U.S. market. With the successful conclusion of its imminent Collection A funding round, the market.
The company has secured its first-ever funding from TNI Fund, a venture arm of Kluz Ventures dedicated to revolutionizing healthcare through innovative technologies. Normal Accomplice to TNI Fund.
4Growth VC, having previously invested €2 million in Saventic Wellbeing in 2022, also increased its stake in this round. Managing Partner at 4Growth Venture Capital.
“‘The company has announced that John Smith, a seasoned professional, serves as CEO of NCBR Funding Fund.'”
